Sulfonyl fluorides and the promotion of diisopropyl fluorophosphate neuropathy

Fundamental and Applied Toxicology

Volumn 33, Issue 2, 1996, Pages 294-297

  Osman, Khaled A ^a,b   Moretto, Angelo ^a   Lotti, Marcello ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Alexandria University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLSULFONYL FLUORIDE; DYFLOS; NEUROTOXIC ESTERASE;

ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; DOSE RESPONSE; DRUG COMPARISON; DRUG POTENTIATION; DRUG SCREENING; ENZYME INHIBITION; IN VITRO STUDY; NERVOUS TISSUE; NEUROPATHY; NONHUMAN;

ANIMALIA; GALLUS GALLUS;

EID: 26844467390     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0167     Document Type: Article

References (15)

1. Aldridge, W. N. (1993). Postscript to the symposium on organophosphorus compound induced delayed neuropathy. Chem. Biol. Interact. 87, 463-466.
2. Aldridge, W. N., and Reiner, E. (1972). Enzyme Inhibitors as Substrates. North Holland Publ. Co., Amsterdam/London.
3. Dixon, W. J. (1992). BMDP Statistical Software Manual. Univ. of California Press, Los Angeles.
4. Ellman, G. L., Courtney, K. K., Andres, W., Jr., and Featherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
5. Johnson, M. K. (1970). Organophosphorus and other inhibitors of brain "Neurotoxic Esterase" and the development of delayed neurotoxicity. Biochem. J. 120, 523-531.
6. Johnson, M. K. (1977). Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential. Arch. Toxicol. 37, 113-115.
7. Johnson, M. K. (1990). Organophosphates and delayed neuropathy - Is NTE alive and well? Toxicol. Appl. Pharmacol. 102, 385-399.
8. Johnson, M. K., and Read, D. J. (1993). Prophylaxis against and promotion of organophosphate-induced delayed neuropathy by phenyl di-n-pentylphosphinate. Chem. Biol. Interact. 87, 449-455.
9. Lotti, M., Caroldi, S., Capodicasa, E., and Moretto, A. (1991). Promotion of organophosphate induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. Toxicol. Appl. Pharmacol. 108, 234-241.
10. Lotti, M., Moretto, A., Capodicasa, E., Bertolazzi, M., Peraica, M., and Scapellato, M. L. (1993). Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicol. Appl. Pharmacol. 122, 165-171.
11. Lotti, M., Moretto, A., Bertolazzi, M., Peraica, M., and Fioroni, F. (1995). Organophosphate polyneuropathy and neuropathy target esterase: Studies with methamidophos and its resolved optical isomers. Arch. Toxicol. 69, 330-336.
12. Moretto, A., Lotti, M., and Spencer, P. S. (1989). In vivo and in vitro regional differential sensitivity of neuropathy target esterase to di-n-butyl-2,2 dichlorovinyl phosphate. Arch. Toxicol. 63, 469-473.
13. Moretto, A., Bertolazzi, M., and Lotti, M. (1994). The phosphorothioic acid-O-(2-chloro-2,3,3-trifluorocyclobutyl)-O-ethyl S-propyl ester promotes organophosphate polyneuropathy without inhibition of neuropathy target esterase. Toxicol. Appl. Pharmacol. 129, 133-137.
14. Pope, C. N., and Padilla, S. (1990). Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. J. Toxicol. Environ. Health 31, 261-273.
15. Randall, J. C., Jianmongkol, S., and Richardson, R. J. (1993). Potentiation of organophosphate-induced delayed neuropathy (OPDIN): selective effect on perching ability in hens produced by serine protease inhibitors. Toxicologist 13, 123.